
Osteopetrosis: new opportunity of treatment thanks to a licensing agreement
SiSaf announces a research collaboration and licensing agreement with the University of L’Aquila to develop Bio-Courier® targeted small interfering RNAs (siRNA) for the treatment of the debilitating bone